Related references
Note: Only part of the references are listed.Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression
Congping Su et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Hedychium coronarium Rhizomes: Promising Antidiabetic and Natural Inhibitor of α-Amylase and α-Glucosidase
Suchitra K. Panigrahy et al.
JOURNAL OF DIETARY SUPPLEMENTS (2020)
Atrial and brain natriuretic peptides: Hormones secreted from the heart
Yasuaki Nakagawa et al.
PEPTIDES (2019)
Galectin-1 attenuates cardiomyocyte hypertrophy through splice -variant specific modulation of Cav1.2 calcium channel
Jia Fan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Investigating β-adrenergic-induced cardiac hypertrophy through computational approach: classical and non-classical pathways
Ali Khalilimeybodi et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2018)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway
Weichun Qian et al.
FRONTIERS IN PHARMACOLOGY (2018)
Heart failure with reduced ejection fraction
Michelle W. Bloom et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy
Bin Zhang et al.
SCIENTIFIC REPORTS (2017)
Physiological and pathological cardiac hypertrophy
Ippei Shimizu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL)
Gang Chen et al.
SCIENTIFIC REPORTS (2016)
Mechanotransduction in Cardiac Hypertrophy and Failure
Robert C. Lyon et al.
CIRCULATION RESEARCH (2015)
The critical role of Akt in cardiovascular function
Prasanna Abeyrathna et al.
VASCULAR PHARMACOLOGY (2015)
DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
Yong Wang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Targeting myocardial remodelling to develop novel therapies for heart failure A position paper from the Working Group on Myocardial Function of the European Society of Cardiology
Guido Tarone et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Isoproterenol induced hypertrophy and associated signaling pathways are modulated by Somatostatin in H9c2 cells
Rishi K. Somvanshi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure
Xinli Li et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Targeting myocardial substrate metabolism in heart failure: potential for new therapies
Hossein Ardehali et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro
Sarah J. Watkins et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2011)
Swietenine: A potential oral hypoglycemic from Swietenia macrophylla seed
Salikat Dewanjee et al.
FITOTERAPIA (2009)
Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats
Fuuun Kawano et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2009)
Mechanisms of disease: Cardiac plasticity
Joseph A. Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Differential activation of CREB by Akt1 and Akt2
Satomi Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Share Paper
